# HCG Clinical Dosing Guidelines

## Overview
Human Chorionic Gonadotropin (HCG) is a glycoprotein hormone that mimics luteinizing hormone (LH) and stimulates testosterone production in males and supports ovulation in females. It is used for fertility treatment, hypogonadism management, and testosterone therapy support.

## Clinical Research Summary
Based on clinical trials and medical use, HCG has demonstrated efficacy in:
- Male hypogonadotropic hypogonadism
- Female ovulation induction
- Testosterone replacement therapy support
- Cryptorchidism treatment in children
- Fertility enhancement in both sexes
- Testicular function preservation

## Standard Concentrations

### Reconstitution Options (International Units - IU)
- **Option 1**: 1000 IU/ml (dilute 5000 IU in 5 ml bacteriostatic water)
- **Option 2**: 500 IU/ml (dilute 5000 IU in 10 ml bacteriostatic water)
- **Option 3**: 2000 IU/ml (dilute 10000 IU in 5 ml bacteriostatic water)

### Storage
- **Lyophilized**: Store at 39-46°F, stable for 24+ months
- **Reconstituted**: Store at 39°F, use within 30-60 days
- **Stability**: Follow manufacturer guidelines for specific products

## Clinical Dosing Protocols

### Male Hypogonadism Treatment

#### Standard Testosterone Support Protocol:
- **Concentration**: 1000 IU/ml
- **Dose**: 500-1000 IU per injection
- **Volume**: 0.5-1.0 ml
- **Frequency**: 2-3 times weekly
- **Duration**: Ongoing with monitoring

#### Post-Steroid Recovery Protocol:
- **Concentration**: 1000 IU/ml
- **Dose**: 1000-3000 IU per injection
- **Volume**: 1.0-3.0 ml
- **Frequency**: 3 times weekly
- **Duration**: 4-6 weeks, then reduce

#### Maintenance TRT Support:
- **Concentration**: 500 IU/ml
- **Dose**: 250-500 IU per injection
- **Volume**: 0.5-1.0 ml
- **Frequency**: 2 times weekly
- **Duration**: Ongoing with TRT

### Female Fertility Treatment

#### Ovulation Induction:
- **Concentration**: 2000 IU/ml
- **Dose**: 5000-10000 IU per injection
- **Volume**: 2.5-5.0 ml
- **Frequency**: Single injection per cycle
- **Timing**: 24-48 hours after follicle maturation

#### IVF Trigger Shot:
- **Concentration**: 2000 IU/ml
- **Dose**: 10000 IU per injection
- **Volume**: 5.0 ml
- **Frequency**: Single injection
- **Timing**: 34-36 hours before egg retrieval

## Dose Calculations by Body Weight and Indication

### Male Hypogonadism (Standard Dosing)
| Body Weight | Low Dose (IU) | Volume (500 IU/ml) | High Dose (IU) | Volume (1000 IU/ml) |
|-------------|---------------|-------------------|---------------|-------------------|
| 110 lbs | 250 IU | 0.5 ml | 500 IU | 0.5 ml |
| 132 lbs | 300 IU | 0.6 ml | 750 IU | 0.75 ml |
| 154 lbs | 350 IU | 0.7 ml | 1000 IU | 1.0 ml |
| 176 lbs | 400 IU | 0.8 ml | 1250 IU | 1.25 ml |
| 198 lbs | 450 IU | 0.9 ml | 1500 IU | 1.5 ml |
| 220 lbs | 500 IU | 1.0 ml | 2000 IU | 2.0 ml |

### Post-Cycle Therapy (PCT) Dosing
| Week | Dose (IU) | Volume (1000 IU/ml) | Frequency |
|------|-----------|-------------------|-----------|
| 1-2 | 2000-3000 IU | 2.0-3.0 ml | 3x weekly |
| 3-4 | 1500-2000 IU | 1.5-2.0 ml | 3x weekly |
| 5-6 | 1000 IU | 1.0 ml | 2x weekly |

### Pediatric Cryptorchidism
| Age | Dose (IU) | Volume (1000 IU/ml) | Frequency | Duration |
|-----|-----------|-------------------|-----------|-----------|
| 4-6 years | 1000 IU | 1.0 ml | 3x weekly | 3 weeks |
| 7-10 years | 1500 IU | 1.5 ml | 3x weekly | 3 weeks |
| >10 years | 2000 IU | 2.0 ml | 3x weekly | 3 weeks |

## Clinical Applications

### Testosterone Replacement Therapy Support:
- **Concentration**: 500-1000 IU/ml
- **Dose**: 250-500 IU twice weekly
- **Duration**: Ongoing with TRT
- **Monitoring**: Testosterone, estradiol, hematocrit

### Fertility Treatment (Male):
- **Concentration**: 1000 IU/ml
- **Dose**: 1000-2000 IU three times weekly
- **Duration**: 3-6 months
- **Monitoring**: Sperm count, testosterone levels

### Fertility Treatment (Female):
- **Concentration**: 2000 IU/ml
- **Dose**: 5000-10000 IU single injection
- **Timing**: Follicular maturation dependent
- **Monitoring**: Ultrasound, estradiol levels

### Weight Loss Protocol (Controversial/Off-label):
- **Concentration**: 500 IU/ml
- **Dose**: 125-250 IU daily
- **Duration**: 3-6 weeks
- **Note**: Not FDA approved for weight loss

## Administration Guidelines

### Injection Technique:
1. Use 25-27 gauge, 1-1.5 inch needle for IM
2. Use 27-30 gauge, 0.5 inch needle for SubQ
3. Clean injection site with alcohol
4. IM sites: Gluteus, vastus lateralis, deltoid
5. SubQ sites: Abdomen, thigh
6. Inject slowly and steadily

### Route Selection:
- **Intramuscular**: Traditional route, may have better absorption
- **Subcutaneous**: Easier administration, good bioavailability
- **Volume**: Large volumes (>1ml) prefer IM injection

### Timing Considerations:
- **TRT Support**: Same days as testosterone injections
- **Fertility**: Precise timing crucial for ovulation induction
- **Consistency**: Same time of day when possible

## Safety Parameters

### Baseline Testing:
- Testosterone, LH, FSH levels
- Estradiol levels
- Hematocrit and hemoglobin
- Prostate specific antigen (men >40)
- Pregnancy test (women)

### Monitoring During Treatment:
- **Men**: Testosterone, estradiol every 6-8 weeks
- **Women**: Estradiol, ultrasound monitoring
- **All**: Watch for signs of OHSS (women)
- **Long-term**: Hematocrit, lipid profile

### Contraindications:
- Prostate or breast cancer
- Ovarian hyperstimulation syndrome (OHSS)
- Uncontrolled thyroid disorders
- Known hypersensitivity to HCG
- Pregnancy (except specific fertility protocols)

### Adverse Effects:
- Injection site reactions
- Mood changes and irritability
- Acne and oily skin
- Water retention
- Gynecomastia (men, due to estradiol increase)
- Ovarian hyperstimulation (women)

## Special Considerations

### Estradiol Management:
- HCG can increase estradiol production
- Monitor estradiol levels regularly
- Consider aromatase inhibitor if levels elevated
- Target estradiol: 20-30 pg/ml in men

### Fertility Considerations:
- **Men**: Maintain testicular function during TRT
- **Women**: Precise timing critical for success
- **Both**: May improve natural fertility
- **Monitoring**: Regular sperm analysis (men)

### Drug Interactions:
- May interact with testosterone therapy
- Monitor when used with fertility drugs
- Consider timing with other hormones
- Coordinate with comprehensive hormone therapy

### Age-Related Factors:
- **Young Men**: Often very responsive
- **Older Men**: May require higher doses
- **Women**: Age affects ovarian response
- **Children**: Use only for approved indications

## Clinical Endpoints

### Male Treatment Success:
- Normalized testosterone levels (300-1000 ng/dl)
- Maintained testicular size
- Improved sperm production
- Enhanced libido and sexual function
- Stable estradiol levels

### Female Treatment Success:
- Successful ovulation induction
- Appropriate follicular development
- Pregnancy achievement (if desired)
- Normalized hormone levels
- Absence of OHSS

### Duration Guidelines:
- **Acute Treatment**: 3-6 weeks for PCT
- **TRT Support**: Ongoing as needed
- **Fertility**: 3-6 months trials
- **Maintenance**: Individualized protocols

### Combination Therapy:
- Often combined with testosterone in men
- Used with FSH in fertility protocols
- May require estradiol management
- Coordinate with comprehensive reproductive care